Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
measles
Fierce Biotech
As measles surges, the first treatment remains a pipe dream
Measles drug development is fraught with challenges, and there are no approved drugs for the disease or any being tested in clinical trials.
Darren Incorvaia
Jul 17, 2025 2:02pm
Fierce Pharma
ACIP floats new subcommittee to scrutinize childhood vaccines
Jun 26, 2025 7:54am
HHS, RFK Jr. sued over $11B grant cuts as measles threat rises
Apr 25, 2025 3:55pm
2nd US child dies of measles amid Texas outbreak
Apr 7, 2025 6:15am
Misinformation, CDC cuts hinder measles, avian flu responses
Mar 14, 2025 6:15am
RFK Jr. says US measles outbreak 'top priority' at HHS
Mar 1, 2025 6:30pm